This conference has been made possible through the generous support of:




ABOUT OUR SPONSORS
PLATINUM
CSL Behring
As a global leader in the plasma protein biotherapeutics industry, we research, develop, manufacture and market biotherapies used to treat serious diseases. Our five core company values underscore our commitment to providing the best possible therapies and services.
For more information on CSL Behring, please visit our Web site. - CSL Behring
Alexion Pharma Canada is a division of Alexion Pharmaceuticals, Inc., a biopharmaceutical company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Alexion is engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with a wide array of severe disease states, including hematologic and kidney diseases, transplant, cancer, and autoimmune disorders. Soliris is Alexion's first marketed product, approved in the U.S. and Europe in 2007, and Canada and Australia in 2009. Alexion is evaluating other potential indications for Soliris as well as other formulations of eculizumab for additional clinical indications.
For more information on Alexion, please visit our Web site. - Alexion
Canadian Blood Services is a national, not-for-profit charitable organization that manages the supply of blood and blood products in all provinces and territories outside of Quebec. Canadian Blood Services also oversees the OneMatch Stem Cell and Marrow Network and provides national leadership for organ and tissue donation and transplantation.
Throughout the year, Canadian Blood Services operates 41 permanent blood collection sites and holds more than 20,000 donor clinics. During the 2008/2009 year, more than one million units of whole blood, plasma and platelets were collected.
For more information on the Canadian Blood Services, please visit our Web site. - Canadian Blood Seervices
Héma-Québec
Created in September 1998, Héma-Quebec's mission is to efficiently provide adequate quantities of safe, optimal blood components, blood substitutes, human tissues and cord blood to meet the needs of all Quebec residents; provide and develop expertise, along with specialized and innovative services and products in the fields of transfusion medicine and human tissue transplantation. Héma-Québec has 1,300 employees, some 2,000 blood drives and more than 300,000 blood donors every year, 16,000 partner volunteers and more than 485,000 blood products delivered to hospitals in Quebec annually to fulfill the needs of patients.
For more information on Héma-Québec, please visit our Web site. - Héma-Québec
For more information on Celgene, please visit our Web site.
Novartis
For more information on Novartis, please visit our Web site.
Shire
For more information on Shire, please visit our Web site.
As a global leader in the plasma protein biotherapeutics industry, we research, develop, manufacture and market biotherapies used to treat serious diseases. Our five core company values underscore our commitment to providing the best possible therapies and services.
- Customer focus
- Innovation
- Integrity
- Collaboration
- Superior performance
For more information on CSL Behring, please visit our Web site. - CSL Behring
GOLD
AlexionAlexion Pharma Canada is a division of Alexion Pharmaceuticals, Inc., a biopharmaceutical company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Alexion is engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with a wide array of severe disease states, including hematologic and kidney diseases, transplant, cancer, and autoimmune disorders. Soliris is Alexion's first marketed product, approved in the U.S. and Europe in 2007, and Canada and Australia in 2009. Alexion is evaluating other potential indications for Soliris as well as other formulations of eculizumab for additional clinical indications.
For more information on Alexion, please visit our Web site. - Alexion
SILVER
Canadian Blood ServicesCanadian Blood Services is a national, not-for-profit charitable organization that manages the supply of blood and blood products in all provinces and territories outside of Quebec. Canadian Blood Services also oversees the OneMatch Stem Cell and Marrow Network and provides national leadership for organ and tissue donation and transplantation.
Throughout the year, Canadian Blood Services operates 41 permanent blood collection sites and holds more than 20,000 donor clinics. During the 2008/2009 year, more than one million units of whole blood, plasma and platelets were collected.
For more information on the Canadian Blood Services, please visit our Web site. - Canadian Blood Seervices
Héma-Québec
Created in September 1998, Héma-Quebec's mission is to efficiently provide adequate quantities of safe, optimal blood components, blood substitutes, human tissues and cord blood to meet the needs of all Quebec residents; provide and develop expertise, along with specialized and innovative services and products in the fields of transfusion medicine and human tissue transplantation. Héma-Québec has 1,300 employees, some 2,000 blood drives and more than 300,000 blood donors every year, 16,000 partner volunteers and more than 485,000 blood products delivered to hospitals in Quebec annually to fulfill the needs of patients.
For more information on Héma-Québec, please visit our Web site. - Héma-Québec
BRONZE
CelgeneFor more information on Celgene, please visit our Web site.
Novartis
For more information on Novartis, please visit our Web site.
Shire
For more information on Shire, please visit our Web site.





